tiprankstipranks
Trending News
More News >
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Revenue

Compare
561 Followers

Cogent Biosciences Revenue

Cogent Biosciences had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Increased -100.00%. In the fiscal year ending Dec 31, 2024, Cogent Biosciences had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
205
Market Cap
$641.01M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20240.00
Dec 31, 20230.00
Dec 31, 20220.00
Dec 31, 20210.00-7.87M-100.00%
Dec 31, 20207.87M-14.63M-65.02%
Dec 31, 201922.50M12.77M+131.14%
Dec 31, 20189.73M1.37M+16.44%
Dec 31, 20178.36M2.00M+31.55%
Dec 31, 20166.36M3.37M+112.83%
Dec 31, 20152.99M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis